Cargando…
Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer
Small molecule inhibitors, such as lapatinib, are effective against breast cancer in clinical trials, but tumor cells ultimately acquire resistance to the drug. Maintaining sensitization to drug action is essential for durable growth inhibition. Recently, adaptive reprogramming of signaling circuitr...
Autores principales: | Azad, A. K. M., Lawen, Alfons, Keith, Jonathan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348014/ https://www.ncbi.nlm.nih.gov/pubmed/28288164 http://dx.doi.org/10.1371/journal.pone.0173331 |
Ejemplares similares
-
Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling
por: Azad, AKM, et al.
Publicado: (2015) -
Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance
por: Fröhlich, Fabian, et al.
Publicado: (2023) -
Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer
por: Okabe, Atsushi, et al.
Publicado: (2021) -
Phosphoproteomics reveals rewiring of the insulin signaling network and multi-nodal defects in insulin resistance
por: Fazakerley, Daniel J., et al.
Publicado: (2023) -
Network rewiring, adaptive resistance and combating strategies in breast cancer
por: Cremers, Constance Gaya, et al.
Publicado: (2019)